(-0.22%) 5 011.12 points
(0.06%) 37 775 points
(-0.52%) 15 601 points
(3.18%) $85.36
(1.48%) $1.783
(1.18%) $2 426.30
(1.55%) $28.82
(0.28%) $957.20
(0.31%) $0.942
(0.43%) $11.09
(0.34%) $0.807
(0.05%) $93.95
Live Chart Being Loaded With Signals
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe...
Stats | |
---|---|
Today's Volume | 86 135.00 |
Average Volume | 69 437.00 |
Market Cap | 315.45M |
EPS | £0 ( 2023-11-08 ) |
Next earnings date | ( £0 ) 2024-06-13 |
Last Dividend | £0.200 ( 2001-07-04 ) |
Next Dividend | £0 ( N/A ) |
P/E | -4.10 |
ATR14 | £3.42 (0.37%) |
Biotech Growth Trust PLC Correlation
10 Most Positive Correlations | |
---|---|
AFRN.L | 0.952 |
LXI.L | 0.928 |
LOK.L | 0.925 |
VMUK.L | 0.919 |
ALFA.L | 0.917 |
JMI.L | 0.917 |
BNKS.L | 0.916 |
UTL.L | 0.916 |
SDIP.L | 0.914 |
NOG.L | 0.911 |
10 Most Negative Correlations | |
---|---|
GLB.L | -0.947 |
UD04.L | -0.925 |
AMC.L | -0.918 |
UAI.L | -0.917 |
7DIG.L | -0.916 |
INX.L | -0.912 |
FCCN.L | -0.907 |
BVIC.L | -0.905 |
UNG.L | -0.905 |
TFG.L | -0.903 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Biotech Growth Trust PLC Financials
Annual | 2022 |
Revenue: | £-37.65M |
Gross Profit: | £-37.65M (100.00 %) |
EPS: | £-1.030 |
Q2 | 2023 |
Revenue: | £-5.22M |
Gross Profit: | £-5.22M (100.00 %) |
EPS: | £-0.180 |
Q1 | 2023 |
Revenue: | £-5.22M |
Gross Profit: | £-5.22M (100.00 %) |
EPS: | £-0.180 |
Q4 | 2022 |
Revenue: | £-38.61M |
Gross Profit: | £-38.61M (100.00 %) |
EPS: | £-0.980 |
Financial Reports:
No articles found.
Biotech Growth Trust PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.600 | 1998-07-13 |
Last Dividend | £0.200 | 2001-07-04 |
Next Dividend | £0 | N/A |
Payout Date | 2001-07-30 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | £1.200 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.23 | -- |
Div. Sustainability Score | 1.880 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.0113 | -- |
Year | Amount | Yield |
---|---|---|
1998 | £0.600 | 0.62% |
1999 | £0.400 | 0.57% |
2000 | £0 | 0.00% |
2001 | £0.200 | 0.10% |
2002 | £0 | 0.00% |
2003 | £0 | 0.00% |
2004 | £0 | 0.00% |
2005 | £0 | 0.00% |
2006 | £0 | 0.00% |
2007 | £0 | 0.00% |
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £0 | 0.00% |
2019 | £0 | 0.00% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
NXT.L | Dividend Knight | 2023-07-06 | Annually | 32 | 1.71% | |
FDM.L | Dividend King | 2023-09-21 | Semi-Annually | 10 | 2.54% | |
0KEZ.L | Dividend Knight | 2023-09-22 | Sporadic | 7 | 0.78% | |
SPO.L | Dividend Knight | 2023-07-27 | Sporadic | 3 | 61.25% | |
JUST.L | Dividend King | 2023-08-24 | Annually | 11 | 93.97% | |
CER.L | Dividend Knight | 2023-06-01 | Semi-Annually | 9 | 0.75% | |
PNS.L | Dividend King | 2023-06-29 | Semi-Annually | 31 | 3.82% | |
GHH.L | Dividend Knight | 2023-06-22 | Annually | 27 | 0.91% | |
ANTO.L | Dividend Knight | 2023-08-31 | Semi-Annually | 32 | 2.90% | |
TGA.L | Dividend Royal | 2023-09-20 | Semi-Annually | 3 | 21.05% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 1.050 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.299 | 1.200 | -9.95 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.295 | 1.500 | -4.39 | -6.58 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.298 | 0.800 | -3.51 | -2.81 | [1 - 3] |
quickRatioTTM | 0.298 | 0.800 | -2.95 | -2.36 | [0.8 - 2.5] |
cashRatioTTM | 0.212 | 1.500 | 9.93 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0371 | -1.500 | 9.38 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -176.03 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.159 | 2.00 | -0.0530 | -0.106 | [0 - 30] |
freeCashFlowPerShareTTM | -0.159 | 2.00 | -0.0795 | -0.159 | [0 - 20] |
debtEquityRatioTTM | 0.0390 | -1.500 | 9.84 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 1.000 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 1.044 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.520 | 1.000 | -4.00 | -4.00 | [0.2 - 2] |
assetTurnoverTTM | -0.284 | 0.800 | -5.23 | -4.18 | [0.5 - 2] |
Total Score | 1.880 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -3.95 | 1.000 | -0.500 | 0 | [1 - 100] |
returnOnEquityTTM | -0.295 | 2.50 | -2.82 | -6.58 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.159 | 2.00 | -0.0530 | -0.159 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.159 | 2.00 | -0.0530 | -0.106 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -5.00 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0679 | 1.000 | -0.803 | 0 | [0.1 - 0.5] |
Total Score | -1.857 |
Biotech Growth Trust PLC
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators